MoneyWorks4Me

Biocon informs about institutional investor meet

10 Jun 2021 Evaluate

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, Biocon has informed that a meeting was conducted with Institutional Investor / Research Analysts on 9th June 2021. Further details of the meeting are attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..